← Back to headlines
Gossamer Bio Secures Up to $250 Million Financing With Limited Upfront Capital
Biotech firm Gossamer Bio announced a financing facility of up to $250 million, though only $25 million is expected immediately, raising questions about the company's near-term liquidity runway.
27 Aug, 19:59 — 27 Aug, 19:59
Sources
Showing 1 of 1 sources
